A Radiologist’s Point of View in the Presurgical and Intraoperative Setting of Colorectal Liver Metastases

References

• Van Cutsem E , CervantesA, AdamRet al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol.27, 1386–1422 (2016).
   PubMed Web of Science ®Google Scholar
• Avallone A , PiccirilloMC, AlojLet al. A randomized Phase III study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (optimization of bevacizumab scheduling within chemotherapy scheme). BMC Cancer16, 69 (2016).
   PubMed Web of Science ®Google Scholar
• Izzo F , PalaiaR, AlbinoVet al. Hepatocellular carcinoma and liver metastases: clinical data on a new dual-lumen catheter kit for surgical sealant infusion to prevent perihepatic bleeding and dissemination of cancer cells following biopsy and loco-regional treatments. Infect. Agent. Cancer10, 11 (2015).
   PubMed Web of Science ®Google Scholar
• Izzo F , PiccirilloM, PalaiaRet al. Management of colorectal liver metastases in patients with peritoneal carcinomatosis. J. Surg. Oncol.100, 345–347 (2009).
   PubMed Web of Science ®Google Scholar
• Scaife CL , CurleySA, IzzoFet al. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann. Surg. Oncol.10, 348–354 (2003).
   PubMed Web of Science ®Google Scholar
• Fanotto V , OngaroE, RihawiKet al. HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives. Oncotarget7(42), 69060–69074 (2016).
   PubMedGoogle Scholar
• Rosati G , CordioS, AprileGet al. Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study. Invest. New Drugs30, 1978–1983 (2012).
   PubMed Web of Science ®Google Scholar
• Catalano O , SandomenicoF, VallonePet al. Contrast-enhanced ultrasound in the assessment of patients with indeterminate abdominal findings at positron emission tomography imaging. Ultrasound Med. Biol.42, 2717–2723 (2016).
   PubMed Web of Science ®Google Scholar
• Granata V , CatalanoO, FuscoRet al. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA ‘uptake’ on the hepatobiliary phase of MR imaging. Abdom. Imaging40, 2364–2371 (2015).
   PubMedGoogle Scholar
• Petrillo A , FuscoR, PetrilloMet al. Standardized index of shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur. Radiol.25, 1935–1945 (2015).
   PubMed Web of Science ®Google Scholar
• NCCN clinical practice guidelines in oncology on rectal cancer. Version 2.2015. www.nccn.org.
   Google Scholar
• NCCN clinical practice guidelines in oncology on colon cancer. Version 2.2015. www.nccn.org.
   Google Scholar
• Tirumani SH , KimKW, NishinoMet al. Update on the role of imaging in management of metastatic colorectal cancer. Radiographics34, 1908–1928 (2014).
   PubMed Web of Science ®Google Scholar
• Adam R , De GramontA, FiguerasJet al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist17, 1225–1239 (2012).
   PubMed Web of Science ®Google Scholar
• Khan AZ , Morris-StiffG, MakuuchiM. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J. Hepatobiliary Pancreat. Surg.16, 137–1344 (2009).
   PubMedGoogle Scholar
• Granata V , FuscoR, CatalanoOet al. Early assessment of colorectal cancer patients with liver metastases treated with antiangiogenic drugs: the role of intravoxel incoherent motion in diffusion-weighted imaging. PLoS ONE10(11), e0142876 (2015).
   PubMed Web of Science ®Google Scholar
• Wagner M , RonotM, DoblasSet al. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour. Eur. Radiol.26(1), 206–215 (2016).
   PubMed Web of Science ®Google Scholar
• Bernatik T , StrobelD, HahnEGet al. Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional ultrasonography. J. Ultrasound Med.20, 509–515 (2001).
   PubMed Web of Science ®Google Scholar
• Campani R , CalliadaF, BottinelliOet al. Improved ultrasound sensitivity in detecting focal liver lesions by B-mode harmonic imaging and contrast enhancement. Radiology209, 232 (1999).
   Google Scholar
• Dietrich CF , KratzerW, StrobeDet al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J. Gastroenterol.12, 1699–1705 (2006).
   PubMed Web of Science ®Google Scholar
• Westwood M , JooreM, GruttersJet al. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost–effectiveness analysis. Health Technol. Assess.17, 1–243 (2013).
   Web of Science ®Google Scholar
• Kong WT , JiZB, WangWPet al. Evaluation of liver metastases using contrast-enhanced ultrasound: enhancement patterns and influencing factors. Gut. Liver10, 283–287 (2016).
   PubMed Web of Science ®Google Scholar
• Quaia E , D’OnofrioM, PalumboAet al. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur. Radiol.16, 1599–1609 (2006).
   PubMed Web of Science ®Google Scholar
• Piscaglia F , CorradiF, ManciniMet al. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer7, 171 (2007).
   PubMed Web of Science ®Google Scholar
• Konopke R , KerstingS, SaegerHD, BunkA. Detection of liver lesions by contrast-enhanced ultrasound – comparison to intraoperative findings. Ultraschall Med.26, 107–113 (2005).
   PubMed Web of Science ®Google Scholar
• Larsen LP , RosenkildeM, ChristensenHet al. Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer? Eur. J. Radiol. 69, 308–313 (2009).
   PubMed Web of Science ®Google Scholar
• Dănilă M , PopescuA, SirliRet al. Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases. Med. Ultrason.12, 233–237 (2010).
   PubMed Web of Science ®Google Scholar
• D’Onofrio M , RomaniniL, SerraCet al. Contrast enhancement ultrasound application infocal liver lesions characterization: a retrospective study about guidelines application (SOCEUS-CEUS survey). J. Ultrasound19, 199–106 (2015).
   Google Scholar
• Vialle R , BoucebciS, RicherJPet al. Preoperative detection of hepatic metastases from colorectal cancer: prospective comparison of contrast-enhanced ultrasound and multidetector-row computed tomography (MDCT). Diagn. Interv. Imaging97, 851–855 (2016).
   PubMed Web of Science ®Google Scholar
• Scharitzer M , Ba-SsalamahA, RinglHet al. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur. Radiol.23, 2187–2196 (2013).
   PubMed Web of Science ®Google Scholar
• Berger-Kulemann V , SchimaW, BaroudSet al. Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference. Eur. J. Surg. Oncol.38, 670–676 (2012).
   PubMed Web of Science ®Google Scholar
• Kulemann V , SchimaW, TamandlDet al. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur. J. Radiol. 79, e1–e6 (2011).
   PubMed Web of Science ®Google Scholar
• Sofue K , TsurusakiM, MurakamiTet al. Does gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases? Eur. Radiol. 24, 2532–2539 (2014).
   PubMed Web of Science ®Google Scholar
• Vriens D , van LaarhovenHW, van AstenJJet al. Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate. J. Nucl. Med.50(11), 1777–1784 (2009).
   PubMed Web of Science ®Google Scholar
• Granata V , FuscoR, CatalanoOet al. Peribiliary liver metastases MR findings. Med. Oncol.34(7), 124 (2017).
   PubMed Web of Science ®Google Scholar
• Granata V , CascellaM, FuscoRet al. Immediate adverse reactions to gadolinium-based MR contrast media: a retrospective analysis on 10.608 examinations. Biomed. Res. Int.3918292 (2016).
   PubMed Web of Science ®Google Scholar
• Donati F , BoraschiP, PacciardiFet al. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: correlation between ADC value and histological tumour regression grading. Eur. J. Radiol.91, 57–65 (2017).
   PubMed Web of Science ®Google Scholar
• Granata V , FuscoR, CatalanoOet al. Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for hepatocellular carcinoma: correlation with histologic grade. Oncotarget7(48), 79357–79364 (2016).
   PubMedGoogle Scholar
• Chung WS , KimMJ, ChungYEet al. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases. J. Magn. Reson. Imaging34(2), 345–353 (2011).
   PubMed Web of Science ®Google Scholar
• Donati OF , FischerMA, ChuckNet al. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases. Eur. J. Radiol.82(5), 822–828 (2013).
   PubMed Web of Science ®Google Scholar
• Schulz A , ViktilE, GodtJCet al. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI. Acta Radiol.57, 1040–1048 (2016).
   PubMed Web of Science ®Google Scholar
• Bipat S , van LeeuwenMS, ComansEFet al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis e metaanalysis. Radiology237(1), 123e31 (2005).
   Web of Science ®Google Scholar
• Shim JR , LeeSD, HanSSet al. Prognostic significance of (18)F-FDG PET/CT in patients with colorectal cancer liver metastases after hepatectomy. Eur. J. Surg. Oncol.44(5), 670–676 (2018).
   PubMed Web of Science ®Google Scholar
• Chun YS , VautheyJ-N, BoonsirikamchaiPet al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA302, 2338–2344 (2009).
   PubMed Web of Science ®Google Scholar
• D’Alessandro A , KalayogluM, SollingerHet al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation51, 157–163 (1991).
   PubMed Web of Science ®Google Scholar
• Angulo P . Nonalcoholic fatty liver disease. N. Engl. J. Med.346, 1221–1231 (2002).
   PubMed Web of Science ®Google Scholar
• Kooby DA , FongY, SuriawinataAet al. Impact of steatosis on perioperative outcome following hepatic resection. J. Gastrointest. Surg.7, 1034–1044 (2003).
   PubMed Web of Science ®Google Scholar
• Laurent A , NiccoC, ChereauCet al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res.65, 948–956 (2005).
   PubMed Web of Science ®Google Scholar
• Rubbia-Brandt L , AudardV, SartorettiPet al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol.15, 460–646 (2004).
   PubMed Web of Science ®Google Scholar
• Karoui M , PennaC, Amin-HashemMet al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann. Surg.243, 1–7 (2006).
   PubMed Web of Science ®Google Scholar
• Julie C , LutzMP, AustDet al. Pathological analysis of hepatic injury after oxaliplatin-based neoadjuvant chemotherapy of colorectal cancer liver metastases: results of the EORTC intergroup Phase III study 40983. J. Clin. Oncol.25 (2007).
   PubMedGoogle Scholar
• Aloia T , SebaghM, PlasseMet al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J. Clin. Oncol.24, 4983–4990 (2006).
   PubMed Web of Science ®Google Scholar
• Malik HZ , FaridS, Al-MuktharAet al. A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case–controlled study. Ann. Surg. Oncol.12, 3519–3526 (2007).
   Google Scholar
• Welsh FK , TilneyHS, TekkisPPet al. Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br. J. Cancer96, 1037–1042 (2007).
   PubMed Web of Science ®Google Scholar
• Lorenz M , Staib-SeblerE, GogCet al. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralbl. Chir.128(2), 87–94 (2003).
   PubMed Web of Science ®Google Scholar
• Kooby DA , StockmanJ, Ben-PoratLet al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann. Surg.237, 860–870 (2003).
   PubMed Web of Science ®Google Scholar
• Granata V , FuscoR, CatalanoOet al. Uncommon neoplasms of the biliary tract: radiological findings. Br. J. Radiol.90(1078), 2016056 (2017).
   Web of Science ®Google Scholar
• Arakawa Y , ShimadaM, UtsunomyaTet al. Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol. Res.43, 685–689 (2013).
   PubMed Web of Science ®Google Scholar
• Alexandrino H , OliveiraD, CiprianoMAet al. Oxaliplatin toxicity presenting as a liver nodule – case report. BMC Cancer15, 247 (2015).
   PubMed Web of Science ®Google Scholar
• Schima W , Ba-SsalamahA, KurtaranAet al. Post-treatment imaging of liver tumours. Cancer Imaging7, S28–S36 (2007).
   PubMedGoogle Scholar
• Tirumani SH , KimKW, NishinoMet al. Update on the role of imaging in management of metastatic colorectal cancer. Radiographics34, 1908–1928 (2014).
   PubMed Web of Science ®Google Scholar
• van Kessel CS , BuckensCF, van den BoschMAet al. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann. Surg. Oncol.19, 2805–2813 (2012).
   PubMed Web of Science ®Google Scholar
• Lastoria S , PiccirilloMC, CaracòCet al. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab. J. Nucl. Med.54, 2062–2069 (2013).
   PubMed Web of Science ®Google Scholar
• Mertens J , De BruyneS, Van DammeNet al. Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases. Eur. J. Nucl. Med. Mol. Imaging40, 1214–1222 (2013).
   PubMed Web of Science ®Google Scholar
• Cai J , MaH, HuangFet al. Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis. World J. Surg. Oncol.11, 306 (2013).
   PubMed Web of Science ®Google Scholar
• Cui Y , ZhangXP, SunYSet al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology248, 894–900 (2008).
   PubMed Web of Science ®Google Scholar
• Koh DM , ScurrE, CollinsDet al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am. J. Roentgenol.188, 1001–1008 (2007).
   PubMed Web of Science ®Google Scholar
• Granata V , FuscoR, ReginelliAet al. Radiological assessment of anal cancer: an overview and update. Infect. Agent Cancer11, 52 (2016).
   PubMed Web of Science ®Google Scholar
• Devries AF , GriebelJ, KremserCet al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res.61, 2513–2516 (2001).
   PubMed Web of Science ®Google Scholar
• DeVries AF , KremserC, HeinPAet al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.56, 958–996 (2003).
   PubMed Web of Science ®Google Scholar
• O’Connor JP , RoseCJ, JacksonAet al. DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. Br. J. Cancer105, 139–145 (2011).
   PubMed Web of Science ®Google Scholar
• De Bruyne S , Van DammeN, SmeetsPet al. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. Br. J. Cancer106, 1926–1933 (2012).
   PubMed Web of Science ®Google Scholar
• García-Figueiras R , Baleato-GonzálezS, PadhaniARet al. Advanced imaging of colorectal cancer: from anatomy to molecular imaging. Insights Imaging7, 285–309 (2016).
   PubMedGoogle Scholar
• de Graaf W , van LiendenKP, van GulikTMet al. (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J. Nucl. Med.51(2), 229–236 (2010).
   PubMed Web of Science ®Google Scholar
• de Graaf W , van LiendenKP, DinantSet al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J. Gastrointest. Surg.14, 369–378 (2010).
   PubMed Web of Science ®Google Scholar
• Cieslak KP , HuismanF, BaisTet al. Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization. Surgery162(1), 37–47 (2017).
   PubMed Web of Science ®Google Scholar
• Olthof PB , TomassiniF, HuespePEet al. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: liver volume overestimates liver function. Surgery162(4), 775–783 (2017).
   PubMed Web of Science ®Google Scholar
• Yoshida M , ShiraishiS, SakamotoFet al. Assessment of hepatic functional regeneration after hepatectomy using (99m)Tc-GSA SPECT/CT fused imaging. Ann. Nucl. Med.28(8), 780–788 (2014).
   PubMed Web of Science ®Google Scholar
• Mitomo , TsunodaT, NakamuraK, KuwabaraH. Quantification of intrahepatic non-uniform distributions for assessing impaired function of liver using 99Tcm-DTPA-galactosyl serum albumin liver SPECT scintigraphy. Nucl. Med. Commun.22(5), 505–512 (2001).
   PubMed Web of Science ®Google Scholar
• Fukui A , MuraseK, TsudaTet al. Assessment of liver function in chronic liver diseases and regional function of irradiated liver by means of 99mTc-galactosyl-human serum albumin liver scintigraphy and quantitative spectral analysis. Ann. Nucl. Med.14(6), 467–476 (2000).
   PubMed Web of Science ®Google Scholar
• Tsuda N , OkadaM, MurakamiT. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur. J. Radiol.73, 137–142 (2010).
   PubMed Web of Science ®Google Scholar
• Planchamp C , PastorCM, BalantLet al. Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA. Invest. Radiol.40, 705–714 (2005).
   PubMed Web of Science ®Google Scholar
• Tsuda N , OkadaM, MurakamiT. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest. Radiol.42, 242–247 (2007).
   PubMed Web of Science ®Google Scholar
• Planchamp C , Gex-FabryM, BeckerCDet al. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers. Invest. Radiol.42, 513–521 (2007).
   PubMed Web of Science ®Google Scholar
• Dahlqvist Leinhard O , DahlströmN, KihlbergJet al. Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. Eur. Radiol.22, 642–653 (2012).
   PubMed Web of Science ®Google Scholar
• Tajima T , TakaoH, AkaiHet al. Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J. Comput. Assist. Tomogr.34, 362–366 (2010).
   PubMed Web of Science ®Google Scholar
• Motosugi U , IchikawaT, SouHet al. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EO B-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J. Magn. Reson. Imaging 30, 1042–1046 (2009).
   PubMed Web of Science ®Google Scholar
• Tamada T , ItoK, HigakiAet al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur. J. Radiol.80, 311–316 (2011).
   Web of Science ®Google Scholar
• Motosugi U , IchikawaT, OguriMet al. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Magn. Reson. Imaging29, 1047–1052 (2011).
   PubMed Web of Science ®Google Scholar
• Utsunomiya T , ShimadaM, HanaokaJet al. Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve. J. Gastroenterol.47, 470–476 (2012).
   PubMed Web of Science ®Google Scholar
• Nishie A , UshijimaY, TajimaTet al. Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with Technetium-99m galactosyl serum albumin scintigraphy. Eur. J. Radiol.81, 1100–1104 (2012).
   PubMed Web of Science ®Google Scholar
• Watanabe H , KanematsuM, GoshimaSet al. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging-preliminary observations. Radiology259, 142–150 (2011).
   PubMed Web of Science ®Google Scholar
• Katsube T , OkadaM, KumanoSet al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest. Radiol.46, 277–283 (2011).
   PubMed Web of Science ®Google Scholar
• Kamimura K , FukukuraY, YoneyamaTet al. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices. J. Magn. Reson. Imaging40, 884–889 (2014).
   PubMed Web of Science ®Google Scholar
• Mazzoni G , NapoliA, MandettaSet al. Intra-operative ultrasound for detection of liver metastases from colorectal cancer. Liver Int.28, 88–94 (2008).
   PubMed Web of Science ®Google Scholar
• Ruzzenente A , ConciS, IaconoCet al. Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. J. Gastrointest. Surg.17, 281–287 (2013).
   PubMed Web of Science ®Google Scholar
• Nanashima A , TobinagaS, AboTet al. Usefulness of Sonazoid-ultrasonography during hepatectomy in patients with liver tumors: a preliminary study. J. Surg. Oncol.103, 152–157 (2011).
   PubMed Web of Science ®Google Scholar
• Zacherl J , ScheubaC, ImhofMet al. Current value of intraoperative sonography during surgery for hepatic neoplasms. World J. Surg.26, 550–554 (2002).
   PubMed Web of Science ®Google Scholar
• Schulz A , DormagenJB, DrolsumAet al. Impact of contrast-enhanced intraoperative ultrasound on operation strategy in case of colorectal liver metastasis. Acta Radiol.53, 1081–1087 (2012).
   PubMed Web of Science ®Google Scholar
• Ferrero A , LangellaS, RussolilloNet al. Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease. J. Gastrointest. Surg.16, 806–814 (2012).
   PubMed Web of Science ®Google Scholar
• Conlon R , JacobsM, DasguptaDet al. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur. J. Ultrasound16, 211–216 (2003).
   PubMedGoogle Scholar
• D’Onofrio M , GallottiA, MartoneEet al. Is intraoperative ultrasound (IOUS) still useful for the detection of liver metastases? J. Ultrasound 12, 144–147 (2009).
   PubMedGoogle Scholar
• Arita J , OnoY, TakahashiMet al. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy. Ann. Surg. Oncol.21(Suppl. 3), S390–S397 (2014).
   PubMedGoogle Scholar
• Lencioni R . European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines for the use of contrast agents in liver ultrasound: what is the impact in clinical practice?Eur. Radiol.15(Suppl. 5), e98–e103 (2005).
   PubMedGoogle Scholar
• Hatanaka K , KudoM, MinamiYet al. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology75(Suppl. 1), 42–47 (2008).
   PubMedGoogle Scholar
• Nakano H , IshidaY, HatakeyamaTet al. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. World J. Gastroenterol.14, 3207–3211 (2008).
   PubMed Web of Science ®Google Scholar
• Torzilli G . Contrast-enhanced intraoperative ultrasonography in surgery for liver tumors. Eur. J. Radiol.51(Suppl.), S25–S29 (2004).
   PubMedGoogle Scholar
• Joo I . The role of intraoperative ultrasonography in the diagnosis and management of focal hepatic lesions. Ultrasonography34, 246–257 (2015).
   PubMed Web of Science ®Google Scholar
• Machi J , UchidaS, SumidaKet al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J. Gastrointest. Surg.5, 477–489 (2001).
   PubMed Web of Science ®Google Scholar
• Razafindratsira T , IsambertM, EvrardS. Complications of intraoperative radiofrequency ablation of liver metastases. HPB (Oxford)13, 15–23 (2011).
   PubMed Web of Science ®Google Scholar
• Eng OS , TsangAT, MooreDet al. Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience. J. Surg. Oncol.111, 410–413 (2015).
   PubMed Web of Science ®Google Scholar
• Meloni MF , AndreanoA, FranzaEet al. Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur. J. Radiol. 81, e897–e902 (2012).
   PubMed Web of Science ®Google Scholar
• Santambrogio R , BarabinoM, OpocherE. Laparoscopic ultrasonography for abdominal tumors. Supplement abstracts of the 11th Congress of the World Federation for Ultrasound in Medicine and Biology, May 28–June 1, 2006, Seoul, Korea. Ultras. Med. Biol.32(5), 48 (2006).
   Google Scholar
• Rethy A , Lang⊘T, MårvikR. Laparoscopic ultrasound for hepatocellular carcinoma and colorectal liver metastasis: an overview. Surg. Laparosc. Endosc. Percutan. Tech.23(2), 135–144 (2013).
   PubMed Web of Science ®Google Scholar
• Montorsi M , SantambrogioR, BianchiPet al. Laparoscopy with laparoscopic ultrasound for pretreatment staging of hepatocellular carcinoma: a prospective study. J. Gastrointest. Surg.5, 312–315 (2001).
   PubMed Web of Science ®Google Scholar
• Foroutani A , GarlandAM, BerberEet al. Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch. Surg.135, 933–938 (2000).
   PubMedGoogle Scholar
• Milsom JW , JerbyBL, KesslerHet al. Prospective, blinded comparison of laparoscopic ultrasonography vs. contrastenhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery. Dis. Colon Rectum43, 44–49 (2000).
   PubMed Web of Science ®Google Scholar
• de Castro SM , TillemanEH, BuschORet al. Diagnostic laparoscopy for primary and secondary liver malignancies: impact of improved imaging and changed criteria for resection. Ann. Surg. Oncol.11(5), 522–529 (2004).
   PubMed Web of Science ®Google Scholar
• Fong Y , FortnerJ, SunRLet al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg.230, 309–318 (1999).
   PubMed Web of Science ®Google Scholar
• Jarnagin WR , ConlonK, BodniewiczJet al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer91, 1121–1128 (2001).
   PubMed Web of Science ®Google Scholar
• Dunne DF , GaughranJ, JonesRPet al. Routine staging laparoscopy has no place in the management of colorectal liver metastases. Eur. J. Surg. Oncol.39(7), 721–725 (2013).
   PubMed Web of Science ®Google Scholar